On 2025-11-06, LB Pharmaceuticals Inc (LBRX) announced earnings per share of $-0.61 for the fiscal quarter ending 2025-09-30, missing the average analyst estimate of $-0.57.

The next expected annoucement date for quarterly earnings is 2026-02-05, with an average estimated earnings per share of $-0.50 for the fiscal quarter ending 2025-12-31.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.